Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Murray Joiner

Physical Medicine & Rehabilitation Roanoke, VA Medical Doctor

NPI 1477595973 CMS profile 157203

2726 Electric Road, Roanoke, VA 24018

Open in the dashboard

General payments

$1,674

43 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Murray Joiner of Roanoke, VA is reported in the CMS Open Payments database as having received $1,674 across 43 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 79th percentile of Physical Medicine & Rehabilitation profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $317 14
2024 General $270 11
2023 General $60 4
2022 General $66 3
2021 General $73 2
2020 General $757 7
2019 General $132 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Murray Joiner
  • Physical Medicine & Rehabilitation median
  • Middle half of Physical Medicine & Rehabilitation
  • National median

In program year 2025, general payments to Murray Joiner were reported at $317. Among 4,146 Physical Medicine & Rehabilitation profiles paid that year, the median was $139 and the middle half received between $48 and $410.

Show as a table
Year Murray Joiner Physical Medicine & Rehabilitation median Middle half National median
2019 $132 $133 $45–$390 $163
2020 $757 $88 $29–$272 $114
2021 $73 $116 $33–$360 $132
2022 $66 $123 $40–$378 $149
2023 $60 $131 $43–$396 $160
2024 $270 $141 $45–$409 $164
2025 $317 $139 $48–$410 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic USA, Inc. $791 7 payments
  2. Boston Scientific Corporation $735 32 payments
  3. Medtronic, Inc. $148 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,006 40 payments
  2. Travel and Lodging $580 2 payments
  3. Debt forgiveness $88 1 payment
Products named General payments · program years 2019–2025
  1. SYNCHROMED $701 6 payments
  2. WaveWriter Alpha Prime 16 $156 9 payments
  3. General - Pain Management General - Pain Management_NMD $146 6 payments
  4. INTELLIS $91 1 payment
  5. Clinical Trial Product $85 4 payments
  6. GENERAL - PAIN MANAGEMENT Pain Management $56 1 payment
  7. WAVEWRITER ALPHA $48 1 payment
  8. GENERAL PAIN MANAGEMENT $41 1 payment
  9. SYNCHROMEDII $35 2 payments
  10. Infinion 16 $29 1 payment
  11. Other $51 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

120

Median for Physical Medicine and Rehabilitation: 276

Drug cost

$1,775

Median for Physical Medicine and Rehabilitation: $5,921

Branded share of claims

37.5%

Median for Physical Medicine and Rehabilitation: 11.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 45 $926
Oxycodone Hcl Generic 33 $501
Gabapentin Generic 31 $226
Cyclobenzaprine Hcl Generic 11 $122

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 7,591 Part D prescribers listed as Physical Medicine and Rehabilitation; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 58 billing codes

Paid by Medicare

$687,900

Of which drugs: $3,404

Medicare patients

1,234

Average age 70

Services billed

34,566

695 women, 539 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 37%
Depression 30%
Ischemic heart disease 27%
Chronic kidney disease 24%
COPD 23%
Heart failure 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 549 23,331 $2,006
Injection, ketorolac tromethamine, per 15 mg J1885 Office 215 2,160 $1,030
Injection, orphenadrine citrate, up to 60 mg J2360 Office 42 60 $215
Injection, midazolam hydrochloride, per 1 mg J2250 Office 183 716 $77
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 324 611 $65

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

43 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physical Medicine & Rehabilitation in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record